Innodem Neurosciences
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis (NCT06283524) | Innodem Neurosciences | 2024-03-18 |
| ETNA-MS Device Validation Study (NCT06256731) | Innodem Neurosciences | 2023-12-12 |
| Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis (NCT05661266) | Innodem Neurosciences | 2023-08-16 |
| Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders (NCT05212727) | Innodem Neurosciences | 2022-04-15 |
| Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease (NCT05176704) | Innodem Neurosciences | 2022-04-15 |
| Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI) (NCT05186948) | Innodem Neurosciences | 2022-03-30 |
| Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis (NCT05061953) | Innodem Neurosciences | 2021-10-18 |
Track Innodem Neurosciences automatically
Every clearance here is in the API, with alerts when new ones post.